Med-Tech Innovation May 10, 2021
The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences and healthcare R&D, has announced findings from a survey conducted at its spring conference.
Respondents believe that emerging technologies including AI and blockchain will receive the highest level of investment in life sciences over the next 12 months (38%), followed by infectious diseases (32%), and oncology (14%). Respondents also predict that the biggest contributors to life science innovation post-pandemic will be start-up biotech companies (35%), followed by start-up tech companies (19%), and big pharma/biotech (18%).
Dr Steve Arlington, president of the Pistoia Alliance, said: “Now more than ever, research is occurring at the intersection between industries. Companies must embrace this trend and...
Today's Sponsors
Today's Sponsor